Laser (Selective Retina Therapy) and Drug Combined Intervention in Clinically Significant Diabetic Macular Edema

NCT03759860 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

12

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetic Macular Edema

Interventions

COMBINATION_PRODUCT: R:GEN laser treatment (Selective Retina Therapy) and Lucentis (ranibizumab) combination therapy

Sponsor

CynosureLutronic